Sodium Diuril (Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.))
Welcome to the PulseAid listing for the Sodium Diuril drug offered from Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.). This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) |
NON-PROPRIETARY NAME: | chlorothiazide sodium |
SUBSTANCE NAME: | CHLOROTHIAZIDE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1958-10-03 |
END MARKETING DATE: | 0000-00-00 |
Sodium Diuril HUMAN PRESCRIPTION DRUG Details:
Item Description | Sodium Diuril from Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) |
LABELER NAME: | Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/18mL) |
START MARKETING DATE: | 1958-10-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76478-711_aebe3b0a-b212-49cf-ae95-73f6f4be2e7f |
PRODUCT NDC: | 76478-711 |
APPLICATION NUMBER: | NDA011145 |
Other CHLOROTHIAZIDE SODIUM Pharmaceutical Manufacturers / Labelers: